Novel Biomarkers and the Future Potential of Biomarkers in Inflammatory Bowel Disease

Joint Authors

Duvoisin, Gilles
Lopez, Robert N.
Leach, Steven T.
Lemberg, Daniel A.
Day, Andrew Stewart
Gearry, R. B.

Source

Mediators of Inflammation

Issue

Vol. 2017, Issue 2017 (31 Dec. 2017), pp.1-9, 9 p.

Publisher

Hindawi Publishing Corporation

Publication Date

2017-04-16

Country of Publication

Egypt

No. of Pages

9

Main Subjects

Diseases

Abstract EN

There is increasing importance placed upon noninvasive assessment of gut inflammation.

These tools are likely to be the key in differentiating intestinal inflammatory disease from functional disorders and in monitoring the response to intervention in individuals with known inflammatory conditions.

Although various noninvasive markers are currently available, they have limitations and do not provide ideal utility.

This review focuses on emerging markers of gut inflammation, highlighting the potential of specific markers.

American Psychological Association (APA)

Duvoisin, Gilles& Lopez, Robert N.& Day, Andrew Stewart& Lemberg, Daniel A.& Gearry, R. B.& Leach, Steven T.. 2017. Novel Biomarkers and the Future Potential of Biomarkers in Inflammatory Bowel Disease. Mediators of Inflammation،Vol. 2017, no. 2017, pp.1-9.
https://search.emarefa.net/detail/BIM-1188127

Modern Language Association (MLA)

Duvoisin, Gilles…[et al.]. Novel Biomarkers and the Future Potential of Biomarkers in Inflammatory Bowel Disease. Mediators of Inflammation No. 2017 (2017), pp.1-9.
https://search.emarefa.net/detail/BIM-1188127

American Medical Association (AMA)

Duvoisin, Gilles& Lopez, Robert N.& Day, Andrew Stewart& Lemberg, Daniel A.& Gearry, R. B.& Leach, Steven T.. Novel Biomarkers and the Future Potential of Biomarkers in Inflammatory Bowel Disease. Mediators of Inflammation. 2017. Vol. 2017, no. 2017, pp.1-9.
https://search.emarefa.net/detail/BIM-1188127

Data Type

Journal Articles

Language

English

Notes

Includes bibliographical references

Record ID

BIM-1188127